Brought to you by 
Eleven Biotherapeutics raises $35mm through Series A round; later gets another $10mm
08 May 2012
Executive Summary
Protein therapeutics start-up Eleven Biotherapeutics has raised $35mm through its Series A financing. Flagship Ventures and Third Rock Ventures, which both helped form the company in 2009 with $1mm in seed funding, co-led the round.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Eleven Biotherapeutics raises $35mm through Series A round; later gets another $10mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice